BTS
BB&T Securities’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $27.8M | Buy |
116,032
+2,614
| +2% | +$627K | 0.25% | 106 |
|
2019
Q2 | $32M | Buy |
113,418
+32,328
| +40% | +$9.12M | 0.29% | 93 |
|
2019
Q1 | $23.3M | Buy |
81,090
+1,614
| +2% | +$463K | 0.22% | 116 |
|
2018
Q4 | $20.9M | Sell |
79,476
-2,116
| -3% | -$556K | 0.23% | 113 |
|
2018
Q3 | $22.4M | Sell |
81,592
-1,064
| -1% | -$292K | 0.22% | 118 |
|
2018
Q2 | $19.7M | Buy |
82,656
+301
| +0.4% | +$71.6K | 0.21% | 118 |
|
2018
Q1 | $18.1M | Buy |
82,355
+7,083
| +9% | +$1.56M | 0.2% | 131 |
|
2017
Q4 | $16.9M | Sell |
75,272
-8,251
| -10% | -$1.86M | 0.22% | 117 |
|
2017
Q3 | $15.9M | Sell |
83,523
-218
| -0.3% | -$41.4K | 0.22% | 119 |
|
2017
Q2 | $15.8M | Sell |
83,741
-229,002
| -73% | -$43.1M | 0.23% | 113 |
|
2017
Q1 | $51.7M | Sell |
312,743
-45,534
| -13% | -$7.53M | 0.71% | 25 |
|
2016
Q4 | $44.9M | Hold |
358,277
| – | – | 0.65% | 33 |
|
2016
Q3 | $44.9M | Buy |
358,277
+45,812
| +15% | +$5.74M | 0.67% | 32 |
|
2016
Q2 | $41M | Buy |
312,465
+2,831
| +0.9% | +$372K | 0.64% | 32 |
|
2016
Q1 | $43M | Sell |
309,634
-2,324
| -0.7% | -$323K | 0.71% | 31 |
|
2015
Q4 | $43.5M | Buy |
311,958
+73,311
| +31% | +$10.2M | 0.91% | 21 |
|
2015
Q3 | $33.4M | Sell |
238,647
-4,229
| -2% | -$592K | 0.73% | 39 |
|
2015
Q2 | $39.9M | Sell |
242,876
-6,857
| -3% | -$1.13M | 0.85% | 28 |
|
2015
Q1 | $386M | Sell |
249,733
-107,685
| -30% | -$166M | 0.84% | 26 |
|
2014
Q4 | $449M | Sell |
357,418
-47,262
| -12% | -$59.4M | 1.01% | 21 |
|
2014
Q3 | $484M | Sell |
404,680
-12,778
| -3% | -$15.3M | 1.13% | 20 |
|
2014
Q2 | $449M | Sell |
417,458
-4,309
| -1% | -$4.64M | 1.07% | 24 |
|
2014
Q1 | $420M | Buy |
421,767
+4,368
| +1% | +$4.35M | 1.09% | 25 |
|
2013
Q4 | $386M | Buy |
417,399
+8,935
| +2% | +$8.26M | 1.06% | 27 |
|
2013
Q3 | $342M | Buy |
408,464
+5,961
| +1% | +$4.98M | 1.06% | 24 |
|
2013
Q2 | $329K | Buy |
+402,503
| New | +$329K | 1.08% | 23 |
|